Document Detail


G-CSF in the treatment of acute myeloid leukemia: is it safe?
MedLine Citation:
PMID:  7510194     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Recent studies of granulocyte colony stimulating factor (G-CSF) in the treatment of myeloid leukemia in Japan have revealed that: 1) G-CSF accelerates neutrophil recovery significantly after intensive chemotherapy or bone marrow transplantation (BMT); 2) G-CSF decreases the number of febrile days and the incidence of documented infections; 3) daily administration of G-CSF, starting from two days before chemotherapy or starting from two days after the end of chemotherapy, tended to increase the remission rate; 4) there is no evidence of stimulation by G-CSF of the growth of myeloid leukemia cells if it is used for a short period of time and if the number of leukemic cells is highly reduced by chemotherapy; 5) there is no evidence that G-CSF administration increases relapse rates of leukemia after chemotherapy or BMT. However, until further randomized studies answer these questions, caution must be exercised to avoid unnecessary stimulation of neutrophil production, and G-CSF should not be given to myeloid leukemia patients with a large number of leukemic cells left.
Authors:
R Ohno
Related Documents :
24456714 - Clinical outcome of postoperative highly conformal versus 3d conformal radiotherapy in ...
9053494 - Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in ...
24772334 - The influence of radiation therapy dose escalation on overall survival in unresectable ...
24762494 - Fractionated stereotactic radiosurgery with volumetric modulated arc therapy (rapid arc...
172214 - Cardiomyopathy after widely separated courses of adriamycin exacerbated by actinomycin-...
24760214 - Carbamazepine for prevention of chemotherapy-induced nausea and vomiting: a pilot study.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Leukemia & lymphoma     Volume:  11 Suppl 2     ISSN:  1042-8194     ISO Abbreviation:  Leuk. Lymphoma     Publication Date:  1993  
Date Detail:
Created Date:  1994-04-13     Completed Date:  1994-04-13     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9007422     Medline TA:  Leuk Lymphoma     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  15-9     Citation Subset:  IM    
Affiliation:
Department of Medicine III, Hamamatsu University School of Medicine, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bone Marrow Transplantation
Clinical Trials as Topic
Granulocyte Colony-Stimulating Factor / administration & dosage,  therapeutic use*
Humans
Leukemia, Myeloid, Acute / therapy*
Chemical
Reg. No./Substance:
143011-72-7/Granulocyte Colony-Stimulating Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevention of chemotherapy-induced neutropenia using G-CSF with VACOP-B--a case report.
Next Document:  Distribution of alpha-galactosyl-containing epitopes on Trypanosoma cruzi trypomastigote and amastig...